Trials / Not Yet Recruiting
Not Yet RecruitingNCT04750252
Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint
An Open Label Study to Evaluate Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint
- Status
- Not Yet Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Akan Biosciences, LLC · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to evaluate the safety and tolerability of autologous StroMel™ for the treatment of moderate to severe OA of the knee joint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | StroMel | Autologous MSC |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2027-08-31
- Completion
- 2027-08-31
- First posted
- 2021-02-11
- Last updated
- 2025-01-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04750252. Inclusion in this directory is not an endorsement.